Zobrazeno 1 - 10
of 95
pro vyhledávání: '"E.O. RODIONOV"'
Autor:
E.O. RODIONOV, S.V. MILLER, L.A. EFTEEV, S.A. TUZIKOV, M.M. TSYGANOV, I.V. DERYUSHEVA, N.V. LITVYAKOV, V.A. MARKOVICH, U.B. URMONOV
Publikováno v:
Паёми Сино, Vol 21, Iss 3, Pp 420-425 (2019)
Objective: To study the long-term results of the combined treatment of non-small cell lung cancer (NSCLC) using pre-surgery chemotherapy, radical surgery and personalized adjuvant chemotherapy based on the level of monoresistance genes. Methods: F
Externí odkaz:
https://doaj.org/article/ec05904d8e79461dbd1d23bc8b091b05
Publikováno v:
Паёми Сино, Vol 21, Iss 2, Pp 263-268 (2019)
Objective: To study the effectiveness and tolerability of preoperative chemotherapy (CHT) in combination with radical surgery in patients with esophageal squamous cell carcinoma (ESCC) II-III stages Methods: The results of the combined and surgica
Externí odkaz:
https://doaj.org/article/1126f4711d784295a3a4398c08144399
Autor:
E.O. RODIONOV, S.V. MILLER, S.A. TUZIKOV, T.L. KRAVCHUK, L.N. BONDAR, U.B. URMONOV, O.V. SAVENKOVA
Publikováno v:
Паёми Сино, Vol 20, Iss 4, Pp 479-482 (2018)
Lung involvement in Hodgkin’s lymphoma (HL) occurs from 15% to 40% of cases. In most patients, it is caused by germination of the affected mediastinal lymphatic nodes in the lung parenchyma. Primary pulmonary form of Hodgkin’s lymphoma is a rare
Externí odkaz:
https://doaj.org/article/f2a782974de14cf9be3d3c5e4bac240a
Autor:
Yu.V. Miroshnichenko, S.V. Dolgikh, A.A. Kirsanova, R.A. Golubenko, D.V. Kovlen, E.O. Rodionov
Publikováno v:
Военно-медицинский журнал. 344:69-76
Publikováno v:
Военно-медицинский журнал. 343:61-64
Autor:
Anastasia A Schegoleva, E.O. Rodionov, M.V. Zavyalova, Nikolay A Shefer, Anastasia A Durova, Anton Fedorov, Olga V. Pankova, Tatiana S. Gerashchenko, V. M. Perelmuter, Evgeny B. Topolnitsky, Anna A. Khozyainova, Evgeny V. Denisov
Publikováno v:
Cellular Physiology and Biochemistry, Vol 55, Iss S2, Pp 29-48 (2021)
Despite advances in diagnostics and therapy of non-small cell lung cancer (NSCLC), the problem of prognosis and prevention of tumor progression is still highly important. Even if NSCLC is diagnosed in the early stages, almost a quarter of patients de
Publikováno v:
Военно-медицинский журнал. 342:55-63
Publikováno v:
Военно-медицинский журнал. 342:11-18
Publikováno v:
Военно-медицинский журнал. 342:78-88
Autor:
Evgeny V. Denisov, Sergey V. Vtorushin, Olga V. Pankova, Tatiana S. Gerashchenko, Vladimir M. Perelmuter, Sergey V. Miller, Sergey A. Tuzikov, Liubov A. Tashireva, Dmitry S. Pismenny, E.O. Rodionov, M.V. Zavyalova
Publikováno v:
Frontiers in Oncology
Frontiers in oncology. 2021. Vol. 11. P. 771802 (1-10)
Frontiers in Oncology, Vol 11 (2021)
Frontiers in oncology. 2021. Vol. 11. P. 771802 (1-10)
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe study assessed the possibility of dividing patients into groups based on the assessment of morphological changes in the epithelium of small-caliber bronchi located near the primary tumor in order to predict high and low risks of distant